Similar articles for PMID: 26389104

Year	Number of Results
1991	1
1995	1
1997	2
2002	1
2003	1
2004	4
2005	1
2006	3
2007	3
2008	1
2009	2
2010	3
2012	3
2013	2
2014	8
2015	7
2016	9
2017	10
2018	13
2019	11
2020	5
2021	1
2022	6
2023	0

1

Prevalence and determinants of cannabinoid prescription for the management of chronic noncancer pain: a postal survey of physicians in the Abitibi-Témiscamingue region of Quebec.

St-Amant H, Ware MA, Julien N, Lacasse A. St-Amant H, et al. CMAJ Open. 2015 Apr 2;3(2):E251-7. doi: 10.9778/cmajo.20140095. eCollection 2015 Apr-Jun. CMAJ Open. 2015. PMID: 26389104 Free PMC article.

2

Exploring physicians' comfort level with opioids for chronic noncancer pain.

Scanlon MN, Chugh U. Scanlon MN, et al. Pain Res Manag. 2004 Winter;9(4):195-201. doi: 10.1155/2004/290250. Pain Res Manag. 2004. PMID: 15605133

3

Physicians' beliefs and likelihood of prescribing opioid tamper-resistant formulations for chronic noncancer pain patients.

Turk DC, Dansie EJ, Wilson HD, Moskovitz B, Kim M. Turk DC, et al. Pain Med. 2014 Apr;15(4):625-36. doi: 10.1111/pme.12352. Epub 2014 Jan 21. Pain Med. 2014. PMID: 24612185

4

Academic family medicine physicians' confidence and comfort with opioid analgesic prescribing for patients with chronic nonmalignant pain.

Macerollo AA, Mack DO, Oza R, Bennett IM, Wallace LS. Macerollo AA, et al. J Opioid Manag. 2014 Jul-Aug;10(4):255-61. doi: 10.5055/jom.2014.0213. J Opioid Manag. 2014. PMID: 25162605

5

Opioid Prescribing Practices and Training Needs of Québec Family Physicians for Chronic Noncancer Pain.

Roy É, Côté RJ, Hamel D, Dubé PA, Langlois É, Labesse ME, Thibault C, Boulanger A. Roy É, et al. Pain Res Manag. 2017;2017:1365910. doi: 10.1155/2017/1365910. Epub 2017 Jul 31. Pain Res Manag. 2017. PMID: 28831278 Free PMC article.

6

Perioperative Patient Beliefs Regarding Potential Effectiveness of Marijuana (Cannabinoids) for Treatment of Pain: A Prospective Population Survey.

Khelemsky Y, Goldberg AT, Hurd YL, Winkel G, Ninh A, Qian L, Oprescu A, Ciccone J, Katz DJ. Khelemsky Y, et al. Reg Anesth Pain Med. 2017 Sep/Oct;42(5):652-659. doi: 10.1097/AAP.0000000000000654. Reg Anesth Pain Med. 2017. PMID: 28796754

7

Synthetic cannabinoid for the treatment of severe chronic noncancer pain in children and adolescents.

Sun N, Cunha N, Amar S, Brown S. Sun N, et al. Can J Pain. 2022 Nov 28;6(1):225-231. doi: 10.1080/24740527.2022.2132138. eCollection 2022. Can J Pain. 2022. PMID: 36458026 Free PMC article.

8

Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population-based cohort study.

Alkabbani W, Marrie RA, Bugden S, Alessi-Severini S, Bolton JM, Daeninck P, Leong C. Alkabbani W, et al. Addiction. 2019 Oct;114(10):1791-1799. doi: 10.1111/add.14719. Epub 2019 Jul 19. Addiction. 2019. PMID: 31240747

9

Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.

Sneed RC, May WL, Stencel C. Sneed RC, et al. Pediatrics. 2004 Nov;114(5):e612-25. doi: 10.1542/peds.2004-1063. Pediatrics. 2004. PMID: 15520092

10

Perceptions and Impact of the 2017 Canadian Guideline for Opioid Therapy and Chronic Noncancer Pain: A Cross-Sectional Study of Canadian Physicians.

Busse JW, Douglas J, Chauhan TS, Kobeissi B, Blackmer J. Busse JW, et al. Pain Res Manag. 2020 Feb 17;2020:8380171. doi: 10.1155/2020/8380171. eCollection 2020. Pain Res Manag. 2020. PMID: 32148601 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed